Business and Performance Impact of the Spread of COVID-19
First written in FY2021-Q1. 5 of 11 entries say "Mitigated", first in FY2023-Q2. Latest entry: FY2024-Q3.
The whole theme swung hardest in 2020: 103 of 175 companies on the "Worse" side.
- FY2024-Q3MitigatedAnnual report
「Following the downgrading of COVID-19 under the Infectious Diseases Control Law, the economy is gradually recovering as economic activity rebounds on increased personal consumption and inbound demand.」
The disclosure describes increased personal consumption and inbound demand following the downgrading of the disease classification, together with a rebound in economic activity, indicating that the easing of COVID-19’s impact on economic activity has continued. - FY2024-Q2MitigatedAnnual report
「During the six-month period ended in the second quarter, from 1 April 2023 to 30 September 2023, Japan’s economy continued to recover gradually, with signs of a rebound in social and economic activity accompanying the reclassification of COVID-19 as a Category 5 infectious disease.」
The disclosure states that social and economic activity rebounded and a gradual recovery trend continued following the reclassification of COVID-19 as a Category 5 infectious disease, indicating that the easing of its impact on economic activity continued. - FY2024-Q1MitigatedAnnual report
「The reclassification of COVID-19 under the Infectious Diseases Control Law to Category 5 increased the movement of people in Japan and overseas, and signs of a gradual recovery emerged.」
The disclosure states that the transition of COVID-19 to Category 5 and increased movement of people eased the impact of the spread of infectious disease on economic activity compared with before. - FY2023-Q3MitigatedAnnual report
「During the nine-month period ended in the third quarter, from 1 April 2022 to 31 December 2022, the impact of COVID-19 on global economic activity was generally diminishing, although the measures taken varied from country to country.」
The disclosure states that the impact of COVID-19 on economic activity was generally diminishing, indicating some easing from the impact through the previous fiscal year. It does not state that the risk of infectious disease was eliminated. - FY2023-Q2MitigatedAnnual report
「During the six-month period ended in the second quarter, from 1 April 2022 to 30 September 2022, the global economy continued to recover gradually as the impact of COVID-19 eased. However, uncertainty about the outlook intensified as concerns about inflation were added to the prolonged Russian invasion of Ukraine.」
The disclosure states that the impact of COVID-19 eased and that the global economy continued on a gradual recovery trend. It does not state that the risk of infectious disease was eliminated. - FY2023-Q1Recovery trend under regulatory easingAnnual report
「During the first quarter of the fiscal year under review, from 1 April 2022 to 30 June 2022, the global economy continued to recover gradually as restrictions on economic activity were eased, despite repeated fluctuations in the number of COVID-19 cases. However, the outlook remained uncertain due to the prolonged situation in Ukraine.」
Although the number of cases continued to fluctuate, the disclosure describes the easing of restrictions on economic activity and a gradual recovery trend. It does not state that the risk of infectious disease or uncertainty about the outlook has been eliminated. - FY2022-Q2MaterialisedAnnual report
「Against this backdrop, the food and health food industries, which are major customers of the Group, were significantly affected by the expansion of working from home and the disappearance of inbound demand, among other factors.」
The impact on the food and health food industries from the expansion of working from home and the disappearance of inbound demand continued to be reported during the six-month period ended in the second quarter. - FY2022-Q1MaterialisedAnnual report
「Demand for gelatin for capsules remained strong due to heightened health and disease-prevention awareness during the COVID-19 pandemic, but net sales declined because of disruptions to ocean container transportation.」
While demand increased as health and disease-prevention awareness grew amid the COVID-19 pandemic, sales of gelatin for capsules declined because of disruptions to ocean container transportation. - FY2021MaterialisedAnnual report
「Net sales were ¥30,550 million, down 11.6% year on year, due to the withdrawal from the collagen casing business in the previous fiscal year and the impact of lower sales in Japan. As a result of the decline in net sales, operating income was ¥1,356 million, down 19.8% year on year, while ordinary income was ¥1,364 million, down 24.1% year on year, due mainly to a decrease in equity-method investment income.」
The decline in sales in Japan against the backdrop of the spread of infectious diseases affected full-year results, resulting in lower net sales, operating income and ordinary income. - FY2021-Q2MaterialisedAnnual report
「Against this backdrop, the food and health food industries, which are major customers of the Group, were significantly affected by the expansion of working from home and the disappearance of inbound demand. On the other hand, signs of recovery emerged in the food-service industry due to the end of shortened operating hours for restaurants and consumption-stimulus measures such as the Japanese government’s GO TO campaign. For the Group, revenue was ¥15,205 million, down 18.4% year on year, partly due to the impact of withdrawing from the collagen casing business in the previous fiscal year. Due to the decline in revenue and other factors, operating profit was ¥647 million, down 23.5% year on year, ordinary profit was ¥648 million, down 33.9% year on year, and profit attributable to owners of the parent was ¥351 million, down 46.2% year on year.」
The impact on the food and health food industries continued due to the spread of COVID-19, and revenue, operating profit, ordinary profit and profit attributable to owners of the parent for the cumulative quarter were all below the levels of the same period of the previous year. The Group also disclosed uncertainty related to concerns about a renewed spread of the infection and a prolonged impact. - FY2021-Q1First statedAnnual report
「Against this backdrop, the food and health food industries, which are major customers of the Group, were significantly affected by requests to refrain from going out and the increase in working from home resulting from the spread of COVID-19, as well as requests for restaurants and other food-service businesses to suspend operations. The impact of the spread of COVID-19 during the cumulative first quarter of the current fiscal year is described in “Part 2. Business Overview, 2. Analysis of Financial Position, Operating Results and Cash Flows by Management, (1) Overview of Operating Results.” Depending on developments going forward, it may affect the Group’s financial position and operating results.」
The Group stated that the food and health food industries, its major customers, were affected by the spread of COVID-19, resulting in business impacts including revenue of ¥7,413 million, down 19.9% year on year. It also indicated the possibility of an impact on its financial position and operating results depending on future developments.